Mollie Roth is Corporate Counsel and Vice President of Business Development for Diaceutics, an international change management and consulting firm specializing in personalized medicine. Professor Roth has been a Visiting Faculty Fellow in the College’s Center for the Study of Law, Science & Innovation for the past two years, focusing on the intersection of law and personalized medicine. She soon will earn an LL.M. in Biotechnology and Genomics at the College of Law.
Prior to joining Diaceutics, Professor Roth was an attorney at Nixon Peabody LLP in Washington, D.C., and Kaye Scholer LLP in New York City, where her practice focused on patent and product liability litigation on behalf of the pharmaceutical industry.
Professor Roth graduated cum laude from Vermont Law School where she was a Note Editor on the Vermont Law School Law Review as well as the first 1L to win a place on the Douglas M. Costle Environmental Moot Court Board. Prior to law school, she was a research scientist studying neurotransmitters as a mediator of pain at the College of Pharmacy at Oregon State University.
B.A., Rutgers University (1990)
J.D., Vermont Law School (1996)